32 Biosciences vs ProNAi Therapeutics
32 Biosciences vs ProNAi Therapeutics, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: 32 Biosciences is on 42/100 and ProNAi Therapeutics on 55/100.
Where each one leads
32 Biosciences
- domain rating: 13/100 against 8/100
ProNAi Therapeutics
- our overall score: 55/100 against 42/100
- funding raised: $116M against $12.0M
At a glance
| Measure | 32 Biosciences | ProNAi Therapeutics |
|---|---|---|
| What it is | Develops novel therapeutic antibodies for oncology and autoimmune diseases. | A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies. |
| Category | Biotech, Drug Discovery, Oncology, Autoimmune Diseases | Biotech, Drug Discovery, Clinical Trials, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2017 | 2004 |
| Headquarters | San Diego, United States | Not published |
| Status | Active | Inactive |
Size, funding and growth
| Measure | 32 Biosciences | ProNAi Therapeutics |
|---|---|---|
| Employees | 9 | Not published |
| Total funding | $12.0M | $116M |
| Latest round | Not published | Series D |
| LinkedIn followers | 926 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | 32 Biosciences | ProNAi Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 42/100 | 55/100 |
| Traction | 45/100 | 40/100 |
| Team | 30/100 | 60/100 |
| Community | 3/100 | 15/100 |
| Search visibility | 24/100 | 14/100 |
| Quality | 48/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 13/100 | 8/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | 32 Biosciences | ProNAi Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Not detected |
| Analytics | Google Analytics 4 | Not detected |
What users say
| Measure | 32 Biosciences | ProNAi Therapeutics |
|---|---|---|
| Community ratingVisitor votes on StartupHub | 1.0/5 from 1 vote | Not published |
| Reddit sentimentThreads we track | Not published | 0 positive, 1 negative across 1 thread |
“Biotech stock plunges 68%... how to invest without the risk?. Read this http://www.breakingreportnews.com/pronai-therapeutics-shows-how-investing-in-biotech-ipos-is-a-game-of-chance/ Scary thing is that I was researching this company heavil”r/stocks
32 Biosciences vs ProNAi Therapeutics: common questions
Which is better, 32 Biosciences or ProNAi Therapeutics?
On our 0-100 score ProNAi Therapeutics rates higher (55/100 against 42/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.
How do 32 Biosciences and ProNAi Therapeutics compare on the numbers?
32 Biosciences leads on domain rating (13/100 against 8/100). ProNAi Therapeutics leads on our overall score (55/100 against 42/100), funding raised ($116M against $12.0M).
What do real users say about 32 Biosciences and ProNAi Therapeutics?
ProNAi Therapeutics: 0 positive and 1 negative mentions across 1 Reddit threads we track, mostly in r/stocks.
Read the full 32 Biosciences review and pricing or the ProNAi Therapeutics review and pricing. You can also browse other 32 Biosciences alternatives we track.